Hani I. Kuttab

Hani I. Kuttab

Auto-generated profile, based on publicly available information

Hani I. Kuttab

BerbeeWalsh Department of Emergency Medicine, University of Wisconsin-Madison, Madison, WI; Med Flight, University of Wisconsin-Madison Hospitals and Clinics, Madison, WI

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
JVJoseph D. Lykins V
Joseph D. Lykins V
HKHani I. Kuttab
Hani I. Kuttab
ERErron M. Rourke
Erron M. Rourke
MHMichelle D. Hughes
Michelle D. Hughes
EKEric P. Keast
Eric P. Keast
MWMichael A. Ward
Michael A. Ward

20 November 2020 in Journal of Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
MWMichael A. Ward
Michael A. Ward
HKHani I. Kuttab
Hani I. Kuttab
JVJoseph D. Lykins V
Joseph D. Lykins V
KWKristen Wroblewski
Kristen Wroblewski
MHMichelle D. Hughes
Michelle D. Hughes
JPJohn Purakal
John Purakal
The Surviving Sepsis Campaign guidelines recommend 30 mL/kg of fluids within 3 hours (30by3) of sepsis-induced hypoperfusion, but a national mandate released an allowance for dosing based on ideal instead of actual body weight (IBW/ABW) for obese patients. This study aims to determine the dose-effect of 30by3 for patients with severe sepsis or septic shock (SS/SS) with respect to body mass index (BMI) categories and secondarily, examine the clinical impact of IBW vs. ABW-based dosing. Retrospective cohort study of adults (≥18 years; n = 1,032) with SS/SS presenting to an urban, tertiary-care emergency department. Models include MEDS score, antibiotic timing, lactate, renal and heart failure, among others. The cohort was 10.2% underweight and 28.7% obese. Overall mortality was 17.1% with 20.4% shock mortality. An exponential increase in mortality was observed for each 5 mL/kg under 30by3 for underweight (p = 0.02), but not obese patients. ABW vs IBW-30by3 dosing was reached in 80.0 vs 52.4% (underweight), 56.4 vs 56.9% (normal/overweight), and 23.3 vs 46.0% (obese). Across all BMI categories, there was increased mortality for not reaching ABW-based 30by3 dosing (OR 1.78, 95% CI 1.18-2.69) with no significant impact for IBW (OR 1.28, 95% CI 0.87 -1.91). The increased mortality for failing to reach ABW-dosed 30by3 remained for underweight patients ABW (OR 5.82, 95% CI 1.32-25.57) but not obese patients. Longer ICU stays were observed for not reaching 30by3 based on ABW (β = 2.40, 95% CI 0.84-3.95) and IBW dosing (β = 1.58, 95% CI 0.07-3.08) overall. This effect remained for obese and underweight (except IBW dosing) patients. An exponential, dose-effect increase in mortality was observed for underweight patients not receiving 30by3. Therefore, the mortality impact of under-dosing may be amplified using ABW for underweight patients. Fluid dosing did not impact mortality for obese patients, but we caution against deviation from guidelines without further studies.

17 April 2024 in Air Medical Journal
Verified
Journal Article
Closed access
MHMason A. Hill
Mason A. Hill
JJJarett D. Jones
Jarett D. Jones
SMSimanjit K. Mand
Simanjit K. Mand
CTCraig Tschautscher
Craig Tschautscher
ACAndrew D. Cathers
Andrew D. Cathers
HKHani I. Kuttab
Hani I. Kuttab

29 April 2024 in Air Medical Journal
Verified
Journal Article
Closed access
JJJarett D. Jones
Jarett D. Jones
MHMason A. Hill
Mason A. Hill
SMSimanjit K. Mand
Simanjit K. Mand
CTCraig Tschautscher
Craig Tschautscher
ACAndrew D. Cathers
Andrew D. Cathers
HKHani I. Kuttab
Hani I. Kuttab

21 April 2025 in JEM Reports
Verified
Journal Article
Open access
KFKeenan S. Fine
Keenan S. Fine
CBCaroline C. Bay
Caroline C. Bay
GKGina Krause
Gina Krause
RGRobert E. George
Robert E. George
CLCamille J. LaLiberte
Camille J. LaLiberte
HKHani I. Kuttab
Hani I. Kuttab

27 December 2024 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
KHKayla N. Haffley
Kayla N. Haffley
XDXiangyun Duan
Xiangyun Duan
ENEric Neasi
Eric Neasi
JWJocelyn Wilke
Jocelyn Wilke
DRDana Resop
Dana Resop
HKHani I. Kuttab
Hani I. Kuttab